Condition: MDS · ALL · Other Hematologic Malignant Neoplasms · Sponsor: University Hospital, Brest
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
This description comes directly from the study's public registry record.
Marie-Bérengère, TROADEC, PhD · (33)230338055 · Marie-berengere.troadec@chu-brest.fr
Nathalie DOUET-GUILBERT, MD, PhD · (33)230338055 · nathalie.douet-guilbert@chu-brest.fr
Always discuss trial participation with your own doctor first.
| CHRU de Brest | Brest, France | Recruiting |
| CH Morlaix, service d'hémato clinique | Morlaix, France | Recruiting |
| CHIC, service d'hémato clinique | Quimper, France | Recruiting |
| CH St Brieuc, service d'hémato clinique | Saint-Brieuc, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05009537